Actavis’ recent acquisitions have positioned the Group among the world’s largest companies in the industry. Founded in 1956, the Group has more than 11,000 employees operating in about 40 countries around the globe. Its headquarters are in Iceland.

The Company has modern development and manufacturing facilities in Europe, the US and Asia. The plants produce a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids.